Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Newell

Showing results (21-30 of 519) with videos related to

Pageof 52
Sort By:
Seminars in Oncology|December 22, 1999
Clinical pharmacokinetics of antitumor antifolatesD R Newell
Cancer|June 15, 1983
Nutrition and dietG R Newell
Preventive Medicine|June 1, 1974
Editorial: Anticancer behaviorG R Newell
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
How to develop a successful cancer drug--molecules to medicines or targets to treatments?David R Newell
CA: a Cancer Journal for Clinicians|November 1, 1975
Measuring improved survival of cancer patientsG R Newell
Cancer Surveys|January 1, 1989
Pharmacokinetic determinants of the activity and toxicity of antitumour agentsD R Newell
The New England Journal of Medicine|January 26, 1978
Sounding board. Clinical evaluation of Laetrile: two perspectives. Why the National Cancer Institute chooses a case-record review of LaetrileG R Newell
Journal of the National Cancer Institute|September 1, 1979
The 40-60% problemG R Newell
Preventive Medicine|March 1, 1980
Prevention of cancerG R Newell
British Journal of Cancer|April 16, 2002
Getting the right dose in cancer chemotherapy--time to stop using surface area?D R Newell
Pageof 52

Showing results (21-30 of 519) with videos related to

Sort By:
Pageof 52
Seminars in Oncology|December 22, 1999
Clinical pharmacokinetics of antitumor antifolatesD R Newell
Cancer|June 15, 1983
Nutrition and dietG R Newell
Preventive Medicine|June 1, 1974
Editorial: Anticancer behaviorG R Newell
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
How to develop a successful cancer drug--molecules to medicines or targets to treatments?David R Newell
CA: a Cancer Journal for Clinicians|November 1, 1975
Measuring improved survival of cancer patientsG R Newell
Cancer Surveys|January 1, 1989
Pharmacokinetic determinants of the activity and toxicity of antitumour agentsD R Newell
The New England Journal of Medicine|January 26, 1978
Sounding board. Clinical evaluation of Laetrile: two perspectives. Why the National Cancer Institute chooses a case-record review of LaetrileG R Newell
Journal of the National Cancer Institute|September 1, 1979
The 40-60% problemG R Newell
Preventive Medicine|March 1, 1980
Prevention of cancerG R Newell
British Journal of Cancer|April 16, 2002
Getting the right dose in cancer chemotherapy--time to stop using surface area?D R Newell
Pageof 52